Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Progenity Inc. (NASDAQ:PROG) Announces Expansion Of COVID-19 RT-PCR Test In The…
TG Therapeutics Inc. (NASDAQ:TGTX) Presents Triple Combination Data At 62nd American…
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Provides Updates Of Its 2020 Achievements And…
Heron Therapeutics Inc. (NASDAQ:HRTX) Resubmits HTC-011 New Drug Application To The…
Incyte (NASDAQ:INCY) Releases Phase 3 Jakafi® In Combination with SOC Study…
Finance
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Home
Tags
BioNTech Se
Tag: BioNTech Se
BioNTech SE (NASDAQ:BNTX) Signs Supply Agreement With Fosun Pharma to Supply...
Kate Hudson
-
January 12, 2021
0
BioNTech SE (NASDAQ:BNTX) And Pfizer Inc. (NYSE:PFE) Sign Agreement To Supply...
Gavins Felicity
-
December 8, 2020
0
BioNTech Se (NASDAQ:BNTX) and Pfizer Inc. (NYSE:PFE) Expanding Phase 3 Trial...
Kate Hudson
-
September 22, 2020
0
BioNTech SE (NASDAQ:BNTX) Commences Clinical Study Of BNT162 Vaccine To Treat...
Kate Hudson
-
August 27, 2020
0
BioNTech Se (NASDAQ:BNTX) And EIB Sign €100 Million Financing Agreement for...
Ward Sport
-
June 17, 2020
0
.td-post-views{ display: none !important; }
